Large gap with delayed quotes
|
Last quote
10/16/2025
-
17:30:22
|
Bid
10/16/2025 -
17:40:00
|
Bid Volume |
Ask
10/16/2025 -
21:21:11
|
Ask Volume |
|---|---|---|---|---|
|
315.00
-2.50
(
-0.79% )
|
313.50
|
16 |
0.00
|
7 |
Analysis date: 14.10.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 10.10.2025.
Interest
Strong
Strong
Three stars since 10.10.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 12.08.2025 at a price of 389.00.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Negative
Negative
The stock appears oversold from a technical perspective due to its recent losses. It trades below its forty day technical trend since 23.09.2025.
4wk Rel Perf
-24.55%
-24.55%
The stock appears oversold from a technical perspective, with a four week dividend-adjusted underperformance of of 24.55% behind the STOXX600.
Sensibility
High
High
The stock has been on the high-sensitivity level since 16.09.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by 0.00%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.10%.
Mkt Cap in $bn
5.53
5.53
With a market capitalization between $2 & $8bn, YPSOMED HOLDING AG is considered a mid-cap stock.
G/PE Ratio
1.11
1.11
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
23.27
23.27
The estimated PE is for the year 2028.
LT Growth
24.78%
24.78%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
8
8
Over the last seven weeks, an average of 8 analysts provided earnings per share estimates.
Dividend Yield
1.12%
1.12%
The twelve month estimated dividend yield represents 26.05% of earnings forecasts.
Beta
106
106
For 1% of index variation, the stock varies on average by 1.06%.
Correlation
0.41
0.41
41.10% of stock movements are explained by index variations.
Value at Risk
75.99
75.99
The value at risk is estimated at CHF 75.99. The risk is therefore 24.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
16.03.2005
16.03.2005